Up to 100,000 Hybrid based in Cambridge About the company Our client is a well established, science led drug discovery company with a strong track record of delivering pre-clinical candidates for partners on challenging targets. They combine deep in-house structural and biophysical expertise (X-ray crystallography, NMR and a full suite of biophysical methods) with modern computational chemistry, cheminformatics, machine learning and ...